Kymera Therapeutics (KYMR) PT Raised to $155 at B.Riley
Tweet
Share
E-mailGet Alerts KYMR Hot Sheet
Price: $111.95 -3.33%
Rating Summary:
26 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
26 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
B.Riley analyst Kalpit Patel raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $155.00 (from $117.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Resumes Kymera Therapeutics (KYMR) at Early-Stage Biotech
- Costco Wholesale (COST) PT Lowered to $1,010 at Freedom Broker
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR1,875 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
